Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bone Cancer, Bone Tumor, Solid Tumor Trial in United States (153-Sm-DOTMP (Samarium-153-DOTMP))

Recruiting
  • Bone Cancer
  • +4 more
  • 153-Sm-DOTMP (Samarium-153-DOTMP)
  • Chicago, Illinois
  • +3 more
Aug 18, 2023

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Solid Tumor Trial in United Kingdom, United States (Farletuzumab ecteribulin)

Recruiting
  • Solid Tumor
  • Farletuzumab ecteribulin
  • Tucson, Arizona
  • +26 more
Jan 30, 2023

Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)

Completed
  • Solid Tumor
  • Lymphoma
  • MK-2118 (IT)
  • +2 more
  • La Jolla, California
  • +7 more
Jan 23, 2023

Solid Tumor, Adult Trial in United States (JAB-3312, Binimetinib, Pembrolizumab)

Recruiting
  • Solid Tumor
  • NSCLC
  • Phoenix, Arizona
  • +14 more
Oct 26, 2022

Solid Tumor Trial in United States (VT1021)

Active, not recruiting
  • Solid Tumor
  • Sarasota, Florida
  • +11 more
Oct 21, 2022

Metastatic Cancer, Solid Tumor Trial in Worldwide (Sym021, Sym022, Sym023)

Active, not recruiting
  • Metastatic Cancer
  • Solid Tumor
  • Aurora, Colorado
  • +17 more
Sep 8, 2022

Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

Completed
Has Results
  • Solid Tumor
  • +4 more
  • Mogamulizumab + Nivolumab
  • Gilbert, Arizona
  • +14 more
Jul 27, 2022

Solid Tumor Trial in United States (NeoTCR-P1 adoptive cell therapy, nivolumab, IL-2)

Suspended
  • Solid Tumor
  • NeoTCR-P1 adoptive cell therapy
  • +2 more
  • Duarte, California
  • +8 more
Aug 16, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting
  • All Malignancies
  • +11 more
  • Encinitas, California
  • +9 more
May 20, 2022

Solid Tumor Trial in United States (KITE-718, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Solid Tumor
  • Gilbert, Arizona
  • +11 more
Apr 5, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Solid Tumor Trial in Chicago (Stereotactic body radiotherapy (SBRT), Pembrolizumab)

Active, not recruiting
  • Solid Tumor
  • Chicago, Illinois
    University of Chicago
Mar 14, 2022

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Solid Tumor, Cancer, Recurrent Solid Tumors Trial in Germany, United States (IMA201 Product, IMADetect®)

Recruiting
  • Solid Tumor
  • +3 more
  • IMA201 Product
  • IMADetect®
  • Chicago, Illinois
  • +6 more
Dec 28, 2021

Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)

Terminated
Has Results
  • Solid Tumor
  • Unresectable or Metastatic Melanoma
  • Duarte, California
  • +26 more
Nov 2, 2021

Solid Tumor Trial in Korea, Republic of, United States (RMC-4630, Cobimetinib, Drug: Osimertinib)

Active, not recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +23 more
Aug 31, 2021

Solid Tumor Trial in United States (Epacadostat, Pembrolizumab, Oxaliplatin)

Completed
Has Results
  • Solid Tumor
  • Phoenix, Arizona
  • +15 more
Jul 13, 2021

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Los Angeles, Chicago, Morristown (Q702)

Recruiting
  • Solid Tumor
  • +2 more
  • Los Angeles, California
  • +3 more
Jul 29, 2021

Solid Tumor, Hematologic Malignancies Trial in United States (LGX818)

Terminated
Has Results
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +12 more
Mar 1, 2021

Solid Tumor, Pancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Chicago, Baltimore, Saint Paul (PAC-1)

Completed
  • Solid Tumor
  • +2 more
  • Chicago, Illinois
  • +2 more
Sep 22, 2020

Solid Tumor, Lymphoma Trial in Chicago, Morristown (Ad-p53)

Unknown status
  • Solid Tumor
  • Lymphoma
  • Chicago, Illinois
  • +2 more
Jun 5, 2020